Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Psychedelic-Based Therapeutics for Generalized Anxiety Disorder (GAD) – Interview with Robert Barrow, CEO, MindMed
|
May 01, 2024 |
Developing Conditionally Active Antibodies: Interview with John K. Celebi, President & CEO, Sensei Bio.
|
Apr 24, 2024 |
Treg Cell Therapy for Neurodegenerative Diseases – Interview with Dr. Howard Berman, CEO, Coya Therapeutics
|
Apr 17, 2024 |
Improving Cancer Screening Among Métis Communities: Interview with Margaret Froh, President, Métis Nation of Ontario
|
Apr 10, 2024 |
Cell Therapies for Chronic Kidney Disease: Featuring Bruce Culleton, CEO, ProKidney
|
Apr 03, 2024 |
Tackling Diabetic Kidney Disease: Featuring Robert Perkins, VP, US Medical Affairs (Renal), Bayer
|
Mar 27, 2024 |
People in Life Sciences Series: Day-in-the-Life of a Pharmacovigilance Professional – Interview with Ashish Jain, Senior Director of Clinical Safety and PV, Curis
|
Mar 20, 2024 |
Building Cancer Awareness and Empowering Métis Youth: Featuring Jordyn Playne, President, Métis Nation of Ontario Youth Council
|
Mar 13, 2024 |
Transforming Eye Care: Innovating New Glaucoma and Dry Eye Disease Treatments
|
Mar 06, 2024 |
Rare Disease Day 2024: Highlighting Patient Stories and Advancements in Rare Disease Research
|
Feb 28, 2024 |
Biologics Development in Immunology and Inflammation — Featuring Amir Reichman, CEO of Scinai Immunotherapeutics
|
Feb 21, 2024 |
Novel Approaches in Cancer Immunotherapy — Featuring OncoC4 founder, CEO and CSO Dr. Yang Liu and CFO Abid Ansari
|
Feb 14, 2024 |
New Targeted Treatments for Breast Cancer — Conversation with Dr. Carlos Doti, VP, US Medical Affairs Oncology, AstraZeneca
|
Feb 07, 2024 |
Exploring the Endocannabinoid System for Drug Development, Featuring Punit Dhillon, Chairman & CEO of Skye Bioscience
|
Jan 31, 2024 |
Life Science Trends for 2024
|
Jan 24, 2024 |
Revolutionizing Orthopedic Joint Replacement — Interview with Ben Sexson, Co-Founder, CEO, Monogram Orthopedics
|
Jan 17, 2024 |
Cognitive and Neuropsychiatric Disorders Drug Development, Featuring Dr. Adam Kaplin, Cofounder, President, CSO, MIRA Pharmaceuticals
|
Jan 10, 2024 |
Pneumococcal Vaccination for Adults: Conversation with Vaccine Scientists Dr. Heather Platt and Dr. Ulrike Buchwald from Merck
|
Dec 13, 2023 |
A Focus on Men's Health — Conversation with Fady Boctor, Petros Pharma President and CCO
|
Dec 06, 2023 |
“Off-the-Shelf” Cellular Therapy: Interview with Longeveron CEO Wa'el Hashad
|
Nov 29, 2023 |
Attorney Tope Leyimu Discusses Proposed FDA ban on Hair Relaxer Products Containing Harmful Chemicals
|
Nov 22, 2023 |
Dr. Lahar Mehta Speaks About New Trial to Evaluate ALS Drug for Progressive Supranuclear Palsy
|
Nov 15, 2023 |
FDA Considers Self Administered Nasal Flu Vaccine + Wayne Gretzky Features in GSK RSV Vaccine Ad
|
Nov 08, 2023 |
Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allergan Aesthetics
|
Nov 01, 2023 |
Lead Investigator Dr. Genevieve Neal-Perry Discusses New Trial Data for Astellas’ Menopause Drug Fezolinetant (Veozah)
|
Oct 25, 2023 |
Johnson & Johnson Faces Lawsuit Over Patient Data Breach + Sleepiz’s Sleep Monitoring Device Gets FDA Clearance
|
Oct 18, 2023 |
Advancing CAR T Cell Therapies in Immuno-Oncology – Featuring Dr. Paul Rennert, CEO, CSO, Aleta Biotherapeutics
|
Oct 11, 2023 |
New HPV Vaccine Data Shows Long-Term Impact – Featuring Dr. Elmar Joura from the Medical University of Vienna
|
Oct 04, 2023 |
Interview with Dr. Kristin Yarema, President of Cell Therapy at Poseida Therapeutics
|
Sep 27, 2023 |
Advancements in Blood-Based Biomarker Tests for NASH — Interview with Dr. Tania Kamphaus and Tony Villiotti
|
Sep 20, 2023 |
Insights into New Alzheimer's Treatments: Treating Agitation and First THC-Based Therapeutic in Trials — Interview with IGC's Ram Mukunda and Claudia Grimaldi
|
Sep 13, 2023 |
Discussing Next Generation Chemotherapy Drugs with Processa Pharma’s Dr. David Young
|
Sep 06, 2023 |
More US States Take on Eli Lilly in Court Over Proposed Insulin Pricing Settlement + Regeneron's High Dose Eylea Wins FDA Approval
|
Aug 30, 2023 |
Interview with BriaCell's CEO Dr. William Williams
|
Aug 23, 2023 |
First Oral Tablet for Postpartum Depression + Court Rejects JJ's Latest Bankruptcy Attempt
|
Aug 16, 2023 |
FDA Clearances for World's Smallest Insulin Pump + New Cardiac Biomarker Test
|
Aug 09, 2023 |
In Conversation with Principal Investigator and SME Dr. Lawrence Eichenfield About the FDA Approval of a Drug-Device Combo for Common Skin Infection
|
Aug 02, 2023 |
Point-of-Care Testing for Infectious Diseases: Senzo CEO Jeremy Stackawitz Speaks About Company’s New Lateral Flow Technology
|
Jul 26, 2023 |
Biosimilars and the Problem with PBMs: Interview with Juliana M. Reed, Executive Director of the Biosimilars Forum
|
Jul 19, 2023 |
Opioid Use Disorder and Brixadi Approval: Interview with Dr. Joshua Cohen, Chief Medical Officer at Braeburn
|
Jul 12, 2023 |
Developing More Affordable Cellular Immunotherapies: Interview with CytoMed Therapeutics
|
Jul 05, 2023 |
Xtalks Speaks with Astellas Pharma's VP & Head of BioPharma Development Marci English About Menopause Drug Approval
|
Jun 28, 2023 |
Wireless Charging for Medical Devices: Interview with Resonant Link’s CEO and Co-Founder Dr. Grayson Zulauf
|
Jun 21, 2023 |
In conversation with FNIH’s Dr. Courtney Silverthorn, Director of the AMP Bespoke Gene Therapy Consortium, About New Rare Disease Trial Portfolio
|
Jun 14, 2023 |
AI and ChatGPT for Medical Record Management: Interview with Carm Huntress, CEO and Founder of Credo Health
|
Jun 07, 2023 |
First Topical Gene Therapy + Bausch + Lomb's First Prescription Med for Dry Eye
|
May 31, 2023 |
Veozah the New Drug for Menopausal Hot Flashes + SkinVive the New Dermal Filler
|
May 25, 2023 |
Interview with Dr. Gillian Woollett, VP, Head of Regulatory Strategy and Policy at Samsung Bioepis
|
May 17, 2023 |
World's First RSV Vaccine + First Novel Treatment for ALS
|
May 10, 2023 |
Axonics’ Non-Drug Incontinence Therapy + How AI Can Be Used to Study the Side Effects of Drugs
|
May 03, 2023 |
Interview with Cody Simmons, CEO of DermaSensor, Maker of a Handheld Skin Cancer Evaluation Tool
|
Apr 26, 2023 |
EPA Proposes Stricter Ethylene Oxide Limits + Johnson and Johnson Offers $8.9 Billion Settlement
|
Apr 19, 2023 |
Interview with Wei-Li Shao, President Virtual Care Company Omada Health
|
Apr 12, 2023 |
Pharma By The Numbers: Celebrating 20 Years of Xtalks with an Analysis of the Industry
|
Apr 05, 2023 |
Interview with Definitive Healthcare's VP, Head of Healthcare Consulting, Manu Garg, about Healthcare Commercial Intelligence
|
Mar 29, 2023 |
Interview with Tidepool’s CEO and Co-Founder Howard Look About an Automated Insulin Dosing App for Type 1 Diabetes
|
Mar 22, 2023 |
Interview with Neuromod COO Diarmuid Flavin About the FDA Approval of Tinnitus Treatment Lenire
|
Mar 15, 2023 |
FDA approval of First Geographic Atrophy Treatment and Authorization of First At-Home Combo COVID-19 and Flu Test
|
Mar 08, 2023 |
Interview with Cala Health’s CCO Doug Biehn about Neuromodulation Therapy Cala Trio for Hand Tremors
|
Mar 01, 2023 |
Sunrise’s At-Home Sleep Apnea Test Gets FDA Clearance + BMS-Pfizer Team up with Kareem Abdul Jabbar for AFib Awareness
|
Feb 22, 2023 |
Interview with Polarean Imaging CTO Dr. Bastiaan Driehuys on the FDA Approval of Lung Imaging Drug Device Combo Xenoview
|
Feb 15, 2023 |
Amgen Launches Humira Biosimilar Amjevita + Potential New Blood Test for Early Detection of Alzheimer's
|
Feb 08, 2023 |
Amazon's New $5 Prescription Drug Program + Top 10 Pharma TV Ad Spenders in 2022
|
Feb 01, 2023 |
Interview with Thea Pharma's Susan Benton about Eye Care and the FDA Approval of Iyuzeh
|
Jan 25, 2023 |
XBB.1.5 Omicron Subvariant + FDA Approves AstraZeneca’s New Asthma Inhaler
|
Jan 18, 2023 |
Interview with Breast Surgical Oncologist Dr. Monique Gary on Cancer Health Disparities
|
Jan 11, 2023 |
Life Science Trends for 2023
|
Jan 04, 2023 |
Interview with the leaders at Amylyx, Maker of New FDA Approved ALS Drug Relyvrio
|
Dec 14, 2022 |
FDA Approves First Fecal Matter Therapy + PureTech Reveals New CBD Oral Capsule
|
Dec 07, 2022 |
First Gene Therapy Approved for Hemophilia B + World AMR Awareness Week
|
Nov 30, 2022 |
FDA Approves First Drug to Delay T1D + Positive Data for Pfizer's Maternal RSV Vaccine
|
Nov 23, 2022 |
Novo Nordisk’s Ozempic (Semaglutide) Shortage and Fake Eli Lilly Twitter Account Announces Free Insulin
|
Nov 16, 2022 |
Interview with Eye Health Biotech Santen Pharmaceuticals’ CMO Peter Sallstig
|
Nov 09, 2022 |
FDA Approves Immunotherapies for Multiple Myeloma and Liver Cancer
|
Nov 02, 2022 |
Interview with Cystic Fibrosis and Rare Disease Patient Leader Gunnar Esiason
|
Oct 26, 2022 |
Elon Musk Reveals he Used Novo's Wegovy for Weight Loss + FDA Approval of Nevro's AI Spinal Cord Stimulation System
|
Oct 19, 2022 |
Bimodal Neuromodulation for Tinnitus: Interview with Caroline Hamilton, Clinical Director of Neuromod Devices – Xtalks Life Science Podcast Ep. 81
|
Oct 12, 2022 |
The Neurolenses Solution for Digital Vision Syndrome: Interview with Pierre Bertrand, CEO of Neurolens
|
Oct 05, 2022 |
FDA Approves World’s Most Expensive Gene Therapy for Rare Disease + CDC Concerned About New COVID-19 Variant
|
Sep 28, 2022 |
How Air Pollution Triggers Lung Cancer + Scientists Develop Parkinson's Test Based on Woman's Ability to Smell It
|
Sep 21, 2022 |
FDA Approval of Sanofi's Enzyme Replacement Drug for ASMD + Disney Actress Partners with Medtronic for Diabetes Tech Campaign
|
Sep 14, 2022 |
Fitbit Introduces New Smartwatch with AFib Detection + FDA Approves Imbruvica for Pediatric Patients with cGVHD
|
Sep 07, 2022 |
FDA Approval of First Rapid-Acting Oral Depression Drug + Approval of $2.8 Million Gene Therapy for Rare Blood Disorder
|
Aug 31, 2022 |
Interview with Asaf Zviran, CEO of Cancer Genomics Company C2i Genomics
|
Aug 24, 2022 |
UK Approves First Omicron-Targeting COVID Vaccine + National Immunization Awareness Month
|
Aug 17, 2022 |
New COVID-19 Testing Technology + FDA Approves First Drug for HER2-Low Breast Cancer
|
Aug 10, 2022 |
FDA Approvals for Liquid Epilepsy Drug and a Vitiligo Medication
|
Aug 03, 2022 |
Towards a 'Functional Cure' for Diabetes with Dr. Philip Toleikis, CEO, Sernova Corp
|
Jul 27, 2022 |
Expanded Approval for Gout Drug + Novavax COVID-19 Vaccine Gets FDA Authorization
|
Jul 20, 2022 |
FDA Issues Safety Warning for Blood Cancer Drug + Long COVID Risk Assessment Tool
|
Jul 13, 2022 |
BD Develops New Monkeypox Test + FDA Authorizes COVID-19 Vaccines for Infants
|
Jul 06, 2022 |
Eli Lilly's Olumiant FDA Approved for Alopecia + Alnylam's RNAi Drug Amvuttra Approved for Rare Protein Disorder
|
Jun 22, 2022 |
More Positive Data for Tirzepatide Weight Loss Injection + Sandoz's Global Biosimilars Awareness Campaign
|
Jun 15, 2022 |
Interview with Georgia Tech’s Dr. Woon-Hong Yeo About a New Smart Stent Platform for Wireless Vascular Monitoring
|
Jun 08, 2022 |
Interview with Dr. Samantha Dale Strasser, CSO and Co-Founder of Transomics Drug Discovery Start-Up "Pepper Bio"
|
Jun 01, 2022 |
FDA Approves New Type 2 Diabetes Injection Mounjaro + US Reports First Case of Monkeypox
|
May 25, 2022 |
Messaging Program Improves Lifestyle Among Heart Attack Survivors + FDA Places Stricter Restrictions on Janssen COVID-19 Vaccine
|
May 18, 2022 |
FDA Approves Bristol Myers' Cardiac Drug for HCM + New Ovarian Cancer Blood Test
|
May 11, 2022 |
First FDA-Approved Treatment for Chronic Yeast Infection + Eli Lilly Obesity Drug Shows Promise in Trials
|
May 04, 2022 |
World Immunization Week 2022 + New COVID-19 Breath Test Gets FDA Authorization
|
Apr 27, 2022 |
BioNTech Partners for mRNA Vaccine Delivery Tech + Pfizer Acquires ReViral for RSV Therapeutics
|
Apr 20, 2022 |
Statins May Lower Parkinsonism Risk + New Genetic Test to Prevent Deafness in Babies
|
Apr 13, 2022 |
Clinical Trial Diversity Insights from NIH Experts + WHO and Polluted Air on World Health Day 2022
|
Apr 06, 2022 |
Pfizer Recalls Blood Pressure Medication + Jazz Pharma Manufacturing Cannabis-Based Medications
|
Mar 30, 2022 |
Exact Sciences and Katie Couric's Colon Cancer Awareness TV Ad + Alnylam Sues Pfizer and Moderna Over Patent Infringements
|
Mar 23, 2022 |
Johnson & Johnson Funding Human Asbestos Studies + Swift Medical's Imaging Device for Remote Digital Wound Care
|
Mar 16, 2022 |
Celebrating Women's Leadership in Life Sciences on International Women's Day + Johnson & Johnson's Cell Therapy for Multiple Myeloma Gets FDA Approval
|
Mar 09, 2022 |
Marking Rare Disease Day 2022 by Sharing Colours + Why Black People Remain Underrepresented in Clinical Trials
|
Mar 02, 2022 |
BioNTech Unveils Modular mRNA Factories for Africa + FDA Authorizes Eli Lilly Monoclonal Antibody Effective Against Omicron
|
Feb 23, 2022 |
UK's NHS Backs World's Costliest Drug for Treatment of MLD + Report Finds Increase in Pharma Cybersecurity Threats
|
Feb 16, 2022 |
Inbody's At-Home Real Time Blood Pressure Monitoring + Eli Lilly Announces Investments into New Manufacturing Facilities
|
Feb 09, 2022 |
FDA Approval for First TCR Therapy for Uveal Melanoma + Pfizer and Moderna Begin Trials for Omicron Booster
|
Feb 02, 2022 |
Gilead Sues Over Counterfeit HIV Drugs + Menarini's New Rapid COVID-19 PCR Test
|
Jan 26, 2022 |
Study Shows Exercise Can Maintain Cognitive Health in Elderly + Abbott's New Cardiac Mapping System
|
Jan 19, 2022 |
New Cancer Blood Test + Bayer Commits to All Green Packaging by 2030
|
Jan 12, 2022 |
FDA and CDC Update Guidelines Amid Omicron + Life Science Trends for 2022
|
Jan 05, 2022 |
Biohaven Intranasal Migraine Drug Gets FDA Approval + Moderna's mRNA Influenza Vaccine
|
Dec 15, 2021 |
Moderna and Pfizer Premature Statements on Omicron + FDA Approves New Hepatitis B Vaccine
|
Dec 08, 2021 |
WHO Declares Omicron Variant of Concern + Seizure Drug Recalled Over Faulty Seal
|
Dec 01, 2021 |
Virtual Reality Treatment for Chronic Pain + Canadian CDMO Biovectra to Build mRNA Manufacturing Plant
|
Nov 24, 2021 |
Xtalks Voices: Magnus Medical CEO Dr. Brett Wingeier Talks About Neurostimulation for Depression
|
Nov 17, 2021 |
Pfizer's COVID-19 Antiviral Pill + FDA Approves AbbVie's Eyedrop for Presbyopia
|
Nov 10, 2021 |
FDA Authorizes Pfizer COVID-19 Vaccine for Children 5 to 11 + Genentech’s Drug Delivery System for Macular Degeneration
|
Nov 03, 2021 |
FDA Approves Interchangeable Humira Biosimilar + Gene Silencing Treatment for Porphyria Gets Nod From England's NICE
|
Oct 27, 2021 |
Moderna Unwilling to Share COVID-19 Recipe + Singer Mary J Blige Partners with Hologic for Breast Cancer Awareness
|
Oct 20, 2021 |
Researchers Develop Arthritis Vaccine + Medtronic Expands Recall on Insulin Pumps
|
Oct 13, 2021 |
CDC Says Flu and COVID-19 Shots Can Be Co-Administered + Merck's Oral Antiviral for COVID-19 Shows Stellar Results
|
Oct 06, 2021 |
New FDA "Bad Ad" Quiz + Pfizer COVID-19 Vaccine Data for Young Children
|
Sep 29, 2021 |
FDA on COVID-19 Vaccine Boosters + Advocacy Group Pushes for Speedy FDA Approval of ALS Drug
|
Sep 22, 2021 |
Eli Lilly to Develop RNA Editing Therapies + Study Shows Benefits of Daily Steps
|
Sep 15, 2021 |
World's First Smart Knee + Alzheimer's Blood Test
|
Sep 08, 2021 |
Why Antimicrobial Resistance is a Silent Pandemic
|
Sep 01, 2021 |
How the Approval of Aducanumab Will Change Alzheimer’s Trials
|
Aug 25, 2021 |
FDA Authorizes COVID-19 Vaccine Boosters for Immunocompromised Individuals
|
Aug 18, 2021 |
AAIC 2021 – COVID-19 Impacts on Cognitive Health + Pancreatic Cancer Blood Test
|
Aug 11, 2021 |
AAIC 2021 - Diversity in Clinical Trials + Johnson & Johnson Sued by Black Women's Group
|
Aug 04, 2021 |
AAIC 2021 – Aduhelm Recommendations + Pfizer's Expanded Chantix Recall
|
Jul 28, 2021 |
WHO Comments on COVID-19 Vaccine Mixing + World's First Glucose Saliva Test
|
Jul 21, 2021 |
Nestlé to Market Oral Microbiome Drug for C. Difficile + WHO Recommends IL-6 Blockers as Life-Saving COVID-19 Treatment
|
Jul 14, 2021 |
First FDA-Approved Video Game for ADHD + Why Not to Worry About Menstrual Changes After COVID-19 Vaccination
|
Jul 07, 2021 |
NeuraLace’s Peripheral Nerve Stimulation System for Chronic Pain + AstraZeneca Fights COVID Vaccine Delivery Lawsuit
|
Jun 30, 2021 |
Measuring Body Fat Percentage with Amazon's Halo app + Regeneron's Antibody Treatment Cuts Risk of COVID-19 Deaths
|
Jun 23, 2021 |
World's First Digital Fabric + Amazon's Direct-to-Consumer COVID-19 Test
|
Jun 16, 2021 |
Fruit and Type 2 Diabetes Risk + Moderna's Manufacturing Partnerships
|
Jun 09, 2021 |
Google's AI Dermatology App + WHO's Investigations into the Coronavirus Lab Leak Theory
|
Jun 02, 2021 |
Clinical Trials Day 2021 + AbbVie’s Humira Monopoly
|
May 26, 2021 |
Pharma TV Ad Spending Trends + AI Algorithm for Heart Disease
|
May 19, 2021 |
Epigenetic Editing with CRISPR + ADHD in Preschoolers
|
May 12, 2021 |
At-Home Sleep Apnea Test + Neurological Rehabilitation Device for Stroke Patients
|
May 05, 2021 |
Malaria Vaccine + Sugar’s Effect on Brain Development in Children
|
Apr 28, 2021 |
J&J COVID-19 Vaccine and Thrombosis + Medtronic's Harmony Transcatheter Pulmonary Valve Approval
|
Apr 21, 2021 |
Parkinson's Disease: Link With Melanoma + Drug Development
|
Apr 14, 2021 |
Social Media’s Disinformation Dozen + Pfizer’s Latest COVID-19 Vaccine Trial Results
|
Apr 07, 2021 |
Caffeine Consumption in Pregnancy + Portable Neuromodulation Stimulator for MS
|
Mar 31, 2021 |
Mask-Associated Dry Eye + Droplet Micron Insulin Needle
|
Mar 24, 2021 |
COVID-19 Pandemic Anniversary + Cancer Biotech Acquisitions
|
Mar 24, 2021 |
Why You Can’t Compare COVID-19 Vaccine Efficacies
|
Mar 24, 2021 |